278 related articles for article (PubMed ID: 20046089)
1. [An epidemiological analysis of hepatitis A virus serologic markers during the recent four years in Korea].
Lee A; Lim HS; Nam CM; Song SM; Yoon HR; Lee KR
Korean J Lab Med; 2009 Dec; 29(6):563-9. PubMed ID: 20046089
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of hepatitis a in South Korea: a nationwide study by the Eone Reference Laboratory.
Cho SE; Kim Y
J Epidemiol; 2013; 23(4):270-4. PubMed ID: 23629647
[TBL] [Abstract][Full Text] [Related]
3. [Is it necessary to investigate anti-hepatitis A virus (HAV) IgM antibodies when the hepatic enzymogram is normal?].
Coitinho C; Marroche D; Toscanini C
Rev Argent Microbiol; 2007; 39(3):166-9. PubMed ID: 17990376
[TBL] [Abstract][Full Text] [Related]
4. Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009.
Kim KA; Lee A; Ki M; Jeong SH
PLoS One; 2017; 12(1):e0170432. PubMed ID: 28099530
[TBL] [Abstract][Full Text] [Related]
5. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.
Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH
World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283
[TBL] [Abstract][Full Text] [Related]
6. Serological study of hepatitis A virus infection amongst the students of a medical college in Delhi & evaluation of the need of vaccination.
Jindal M; Rana SS; Gupta RK; Das K; Kar P
Indian J Med Res; 2002 Jan; 115():1-4. PubMed ID: 12424929
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis A virus seropositivity among healthcare workers at a university hospital in Korea].
Son JS; Lee MS; Kang SY; Lee WI
Korean J Lab Med; 2009 Dec; 29(6):551-6. PubMed ID: 20046087
[TBL] [Abstract][Full Text] [Related]
8. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
9. An in-house-anti-hepatitis A virus (HAV)-specific immunoglobulin M capture enzyme-linked immunosorbent assay: evaluation and application to an HAV outbreak.
Kiyohara T; Ouchi Y; Hasegawa Y; Sato T; Yoneyama T; Ishii K; Ito T; Wakita T
J Med Virol; 2009 Sep; 81(9):1513-6. PubMed ID: 19623670
[TBL] [Abstract][Full Text] [Related]
10. Window period of anti-hepatitis A virus immunoglobulin M antibodies in diagnosing acute hepatitis A.
Lee HK; Kim KA; Lee JS; Kim NH; Bae WK; Song TJ
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):665-8. PubMed ID: 23325281
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis A virus infection in persons with HIV infection in Taiwan: implications for hepatitis A vaccination.
Sun HY; Kung HC; Ho YC; Chien YF; Chen MY; Sheng WH; Hsieh SM; Wu CH; Liu WC; Hung CC; Chang SC
Int J Infect Dis; 2009 Sep; 13(5):e199-205. PubMed ID: 19208490
[TBL] [Abstract][Full Text] [Related]
13. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea.
Jung YM; Park SJ; Kim JS; Jang JH; Lee SH; Kim JW; Park YM; Hwang SG; Rim KS; Kang SK; Lee HS; Yun HS; Jee YM; Jeong SH
J Med Virol; 2010 Aug; 82(8):1318-26. PubMed ID: 20572083
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
15. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance.
Yanez LA; Lucero NS; Barril PA; Díaz Mdel P; Tenaglia MM; Spinsanti LI; Nates SV; Isa MB; Ré VE
J Clin Virol; 2014 Jan; 59(1):38-43. PubMed ID: 24332411
[TBL] [Abstract][Full Text] [Related]
16. Changing epidemiology of hepatitis A infection in Izmir, Turkey.
Kurugol Z; Aslan A; Turkoglu E; Koturoglu G
Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745
[TBL] [Abstract][Full Text] [Related]
17. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
Joshi N; Yr NK; Kumar A
Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015.
Haeri Mazanderani A; Motaze NV; McCarthy K; Suchard M; du Plessis NM
PLoS One; 2019; 14(6):e0216033. PubMed ID: 31242191
[TBL] [Abstract][Full Text] [Related]
19. Multiple factors contribute to positive results for hepatitis A virus immunoglobulin M antibody.
Alatoom A; Ansari MQ; Cuthbert J
Arch Pathol Lab Med; 2013 Jan; 137(1):90-5. PubMed ID: 23276180
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
